Align Technology Inc Stock Price, News & Analysis

Align Technology is focused on expanding digital orthodontics through its Invisalign doctors, announcing an opportunity to capture a global market of 15 million annual orthodontic case starts, with an additional potential of 500 million consumers. CEO Joe Hogan discussed the company's growth strategy, forecasting a CAGR of over 20% over five years, supported by a robust network of over 189,000 Invisalign doctors. The company continues to invest in its digital platform and iTero scanner technology, aiming to drive further adoption of Invisalign treatments.

Align Technology will host a virtual Investor Day on November 23, 2020, from 8:00 a.m. to 1:00 p.m. Eastern time. The event aims to provide insights into the company's future plans and performance. Interested participants must register in advance at registration link. The meeting will be livestreamed on the company’s website with a replay available for three months.

Align Technology (NASDAQ: ALGN) announced that the International Trade Commission (ITC) modified an earlier ruling regarding an investigation against 3Shape A/S. The ITC acknowledged that 3Shape infringed certain Align patents but invalidated those claims while upholding the validity of two other patents. However, it reversed the finding of indirect infringement. Align expressed disagreement with the ITC's decision and is considering further legal action, aiming to safeguard its intellectual property following significant investments in technology.

Align Technology announced the opening of its 2021 Research Award Program, offering up to $300,000 in funding for clinical and scientific dental research worldwide. Since its inception in 2010, the program has awarded approximately $2 million to advance orthodontics and dentistry. This year, awards will be available for research in the Americas, EMEA, and APAC regions, with a focus on improving patient care. Applications must be submitted by March 5, 2021, and recipients will be notified by June 7, 2021.

Align Technology reported impressive Q3 2020 results with total revenues at $734.1 million, marking a 20.9% increase year-over-year. The GAAP diluted net income per share was $1.76, while non-GAAP amounted to $2.25. Clear Aligner volume soared by 28.7% to 496.1 thousand cases. The operating margin improved to 24.1%, a significant 44.8 points increase sequentially. Align also celebrated 9 million Invisalign patients and launched innovative products enhancing treatment options.

Align Technology has announced the launch of Invisalign G8 with SmartForce Aligner Activation, enhancing treatment predictability for crowding, crossbite, and deep bite cases. Leveraging data from over 9 million Invisalign patients, this innovation optimizes tooth movements. Key features include automatic force application and precision bite ramps to improve treatment outcomes, with a reported 2x improvement in incisor intrusion predictability. Invisalign G8 will be available globally in Q1 2021.

Align Technology has filed a lawsuit against 3Shape for infringing seven additional patents in the U.S. District Court for the Western District of Texas. This lawsuit asserts over 30 patents against 3Shape, following a previous determination by the ITC that 3Shape’s scanners violated Align's patents. Align aims to protect its intellectual property and intends to assess further patent assertions against 3Shape if necessary.

Align Technology, Inc. (Nasdaq: ALGN) will announce its third quarter 2020 financial results on October 21, 2020, after market close at 4:00 p.m. ET. The results will be accessible on the Investor Relations section of their website. A conference call is scheduled for 4:30 p.m. ET to discuss these results, available via audio webcast. An archived replay will be accessible within an hour post-call and will be available for one month. Align Technology specializes in clear aligners, intraoral scanners, and CAD/CAM software, improving patient outcomes through advanced digital dentistry.

Align Technology has reached a significant milestone by treating its 1 millionth patient in the Asia Pacific with the Invisalign system, the leading clear aligner technology. This announcement emphasizes the growing adoption of Invisalign, with over 8 million patients worldwide. The milestone was celebrated by highlighting Ayumu Saito, a 23-year-old Olympic hopeful, as the 1 millionth patient. Align Tech is committed to enhancing patient outcomes through digital orthodontics and has contributed over $1 million to Operation Smile, supporting children and adults born with cleft conditions.